Drugs / SOF-SKN
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT07072611 Comparator | Jul 2025 → Feb 2026 overdue | cutaneous lupus erythematosus | Noxopharm Limited | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SOF-SKN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07072611 ↗ |
| Route | Topical | “applied topically” NCT07072611 ↗ |